Inflammatory Skin Diseases Treatment Market (2024 - 2034)
Inflammatory Skin Diseases Treatment Market Study by Corticosteroid, Calcineurin Inhibitors, and Restinoids Treatment with Oral, Topical, and Injectable Products From 2024 to 2034
Core Findings
FREE CustomizationInflammatory Skin Diseases Treatment Market Outlook (2024 to 2034)
Worldwide revenue from the demand for inflammatory skin disease treatment market is estimated to stand at US$ 27.68 billion in 2024 and is slated to increase at a CAGR of 13.5% to reach US$ 97.89 billion by 2034.
According to some very recent studies, it is suggested that skin and subcutaneous diseases, which include inflammatory types majorly affect over 4.8 billion cases annually around the world. Out of all the skin diseases, fungal disease accounts for 34% of total cases, followed by bacterial diseases. These conditions are primarily leading to people focusing more on skin disease treatment to make sure they and their loved ones are safe and secure.
Looking at the country-wise data, India is facing some serious disability burdens due to skin infections, including dermatitis, scabies, and psoriasis. This data is a waking alarm and stimulating more people to look towards some inflammatory skin disease treatments. Such situations are making it quite easy for medicine manufacturers to pocket good profits, as more people get to understand the severity of these issues.
One other factor is that governments around the world focus very seriously on the health of citizens, for instance, the Australian government spends significant per capita on healthcare, with an average of around US$ 7,055 per person. This figure includes all healthcare expenditures, not just for skin diseases; however, it is a very notable component of national healthcare investment and gives a good platform for medicine manufacturers to establish their business in this region.
Skin diseases are caused due to an array of factors, including genetics, hormonal shifts, psychological stress, and food allergies. As more people study the different subjects of medicine, more knowledge is coming out and people are taking active actions to make their lifestyle better to avoid skin diseases. Key players are also putting a hefty amount into research and development to make it possible for more customers to get rid of these inflammatory skin diseases forever.
Some of the most recent developments include the introduction of biological therapies that target specific components of the immune system, such as cytokines. Added to this the use of Janus Kinase inhibitors is also emerging to be a fruitful and promising option for managing atopic dermatitis and other inflammatory skin diseases. Drugs are also manufactured, which are helping to control the symptoms and are making people shift toward safer, long-term treatment options.
| Report Attribute | Detail |
|---|---|
| Inflammatory Skin Diseases Treatment Market Size (2024E) | US$ 27.68 Billion |
| Forecasted Market Value (2034F) | US$ 97.89 Billion |
| Global Market Growth Rate (2024 to 2034) | 13.5% CAGR |
| East Asia Market Value (2024E) | US$ 4.85 Billion |
| Mexico Market Value (2034F) | US$ 3.56 Billion |
| Oral Segment Growth Rate (2024 to 2034) | 13.8% CAGR |
| United States Market Value (2034F) | US$ 35.04 Billion |
| Key Companies Profiled | Amgen Inc.; AbbVie Inc.; Merck & Co; Boerhringer Ingelheim International GmbH; Eli Lilly and Company; Novartis AG |
Inflammatory skin disease treatment is generally associated with wide co-morbidities, such as diabetes and psoriasis arthritis. Inflammatory skin diseases develop at any stage and in any age group. Inflammatory skin diseases are generally caused due to some genetic disposition and other environmental factors. Inflammatory skin diseases usually cause discomfort and anxiety.
The immune system plays an important role in the development of inflammatory skin diseases. Inflammatory skin diseases affect the patient’s mental health, as it is a chronic condition, which has a significant negative impact on the quality of life of those who suffer from the disease.
People with inflammatory skin diseases often suffer from physiological problems, such as low self-esteem, and less coping responses, and have feelings of social stigma, shame, and embarrassment regarding their appearance. Therefore, inflammatory skin diseases have a debilitating effect on the quality of life of people suffering from them. Furthermore, this creates an immediate demand for inflammatory skin disease treatment across the globe.
The increasing prevalence of atopic dermatitis and psoriasis is primarily responsible for driving the growth of the global inflammatory skin disease treatment market. Atopic dermatitis is a type of chronic inflammatory skin condition, which affects around 1/4 of children up to 3% of adults.
However, long-term use of topical corticosteroids sometimes causes several negative side effects, such as damaging skin structure, increasing susceptibility to infections, and interfering with skin repair. In addition, systematic treatment for inflammatory skin diseases is not provided to some patients with kidney or liver diseases, pregnant women, and nursing mothers.
Thus, there is an unmet need for new therapies that are safe for long-term use and drugs that are in the pipeline. These factors are responsible for hampering the growth of the global inflammatory skin diseases treatment market.
Key Players
The key players present in the global inflammatory skin diseases treatment industry are Merck & Co., Inc., Amgen Inc., AbbVie Inc., Boehringer Ingelheim International GmbH, Pfizer Inc., Eli Lilly and Company, Novartis AG, and others.
The report covers an exhaustive analysis on:
- Inflammatory Skin Diseases Treatment Market Segments
- Inflammatory Skin Diseases Treatment Market Dynamics
- Historical Actual Inflammatory Skin Diseases Treatment Market Size, 2019 to 2023
- Inflammatory Skin Diseases Treatment Market Size & Forecast 2024 to 2034
- Inflammatory Skin Diseases Treatment Market Current Trends/Issues/Challenges
- Competition & Companies involved
- Inflammatory Skin Diseases Treatment Market Drivers and Restrain
Regional analysis includes:
- North America
- Latin America
- Europe
- Asia Pacific excluding China
- China
- Middle East & Africa
Report Highlights:
- Shifting Industry dynamics
- In-depth market segmentation
- Historical, current, and projected industry size Recent industry trends
- Key Competition landscape
- Strategies of key players and product offerings
- Potential and niche segments/regions exhibiting promising growth
- A neutral perspective towards market performance
Segmentations of Inflammatory Skin Diseases Treatment Market
-
By Treatment Types :
- Corticosteroids
- Calcineurin Inhibitors
- Retinoids
- Others
-
By Product Type :
- Oral
- Injectable
- Topical
-
By Distribution Channel :
- Hospital Pharmacies
- Retail Pharmacies
- e-Commerce
-
By Region :
- North America
- Western Europe
- Eastern Europe
- Latin America
- East Asia
- South Asia & Pacific
- Middle East & Africa
Table of Content
- 1. Executive Summary
- 2. Industry Introduction, including Taxonomy and Market Definition
- 3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
- 4. Global Market Demand Analysis and Forecast, including Historical Analysis and Future Projections
- 5. Pricing Analysis
- 6. Global Market Analysis and Forecast
- 6.1. Treatment Types
- 6.2. Product Type
- 6.3. Distribution Channels
- 7. Global Market Analysis and Forecast, By Treatment Types
- 7.1. Corticosteroids
- 7.2. Calcineurin Inhibitors
- 7.3. Retinoids
- 7.4. Others
- 8. Global Market Analysis and Forecast, By Product Type
- 8.1. Oral
- 8.2. Topical
- 8.3. Injectable
- 9. Global Market Analysis and Forecast, By Distribution Channels
- 9.1. Hospital Pharmacies
- 9.2. Retail Pharmacies
- 9.3. e-commerce
- 10. Global Market Analysis and Forecast, By Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. Asia Pacific
- 10.6. East Asia
- 10.7. MEA
- 11. North America Sales Analysis and Forecast, by Key Segments and Countries
- 12. Latin America Sales Analysis and Forecast, by Key Segments and Countries
- 13. Western Europe Sales Analysis and Forecast, by Key Segments and Countries
- 14. Eastern Europe Sales Analysis and Forecast, by Key Segments and Countries
- 15. Asia Pacific Sales Analysis and Forecast, by Key Segments and Countries
- 16. East Asia Sales Analysis and Forecast, by Key Segments and Countries
- 17. MEA Sales Analysis and Forecast, by Key Segments and Countries
- 18. Sales Forecast by Treatment Types, Product Type, and Distribution Channels for 30 Countries
- 19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
- 20. Company Profile
- 20.1. Merck & Co., Inc.
- 20.2. Amgen Inc.
- 20.3. AbbVie Inc.
- 20.4. Boehringer Ingelheim International GmbH
- 20.5. Pfizer Inc.
- 20.6. Eli Lilly and Company
- 20.7. Novartis AG
List Of Table
Table 1: Global Market US$ Mn Forecast by Region
Table 2: Global Market US$ Mn Forecast by Treatment Types
Table 3: Global Market US$ Mn Forecast by Product Type
Table 4: Global Market US$ Mn Forecast by Distribution Channels
Table 5: North America Market US$ Mn Forecast by Country
Table 6: North America Market US$ Mn Forecast by Treatment Types
Table 7: North America Market US$ Mn Forecast by Product Type
Table 8: North America Market US$ Mn Forecast by Distribution Channels
Table 9: Latin America Market US$ Mn Forecast by Country
Table 10: Latin America Market US$ Mn Forecast by Treatment Types
Table 11: Latin America Market US$ Mn Forecast by Product Type
Table 12: Latin America Market US$ Mn Forecast by Distribution Channels
Table 13: Western Europe Market US$ Mn Forecast by Country
Table 14: Western Europe Market US$ Mn Forecast by Treatment Types
Table 15: Western Europe Market US$ Mn Forecast by Product Type
Table 16: Western Europe Market US$ Mn Forecast by Distribution Channels
Table 17: Eastern Europe Market US$ Mn Forecast by Country
Table 18: Eastern Europe Market US$ Mn Forecast by Treatment Types
Table 19: Eastern Europe Market US$ Mn Forecast by Product Type
Table 20: Eastern Europe Market US$ Mn Forecast by Distribution Channels
Table 21: Asia Pacific Market US$ Mn Forecast by Country
Table 22: Asia Pacific Market US$ Mn Forecast by Treatment Types
Table 23: Asia Pacific Market US$ Mn Forecast by Product Type
Table 24: Asia Pacific Market US$ Mn Forecast by Distribution Channels
Table 25: East Asia Market US$ Mn Forecast by Country
Table 26: East Asia Market US$ Mn Forecast by Treatment Types
Table 27: East Asia Market US$ Mn Forecast by Product Type
Table 28: East Asia Market US$ Mn Forecast by Distribution Channels
Table 29: MEA Market US$ Mn Forecast by Country
Table 30: MEA Market US$ Mn Forecast by Treatment Types
Table 31: MEA Market US$ Mn Forecast by Product Type
Table 32: MEA Market US$ Mn Forecast by Distribution Channels
List Of Figures
Figure 1: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types
Figure 2: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 3: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 4: Global Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Region
Figure 5: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types
Figure 6: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 7: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 8: North America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 9: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types
Figure 10: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 11: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 12: Latin America Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 13: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types
Figure 14: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 15: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 16: Western Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 17: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types
Figure 18: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 19: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 20: Eastern Europe Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 21: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types
Figure 22: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 23: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 24: Asia Pacific Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 25: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types
Figure 26: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 27: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 28: East Asia Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
Figure 29: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Treatment Types
Figure 30: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Product Type
Figure 31: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Distribution Channels
Figure 32: MEA Market Value Share (%), Growth Rate (Y-o-Y), and US$ Mn Projection by Country
- FAQs -
What are the factors driving the growth of the inflammatory skin diseases treatment market?
The increasing prevalence of atopic dermatitis and psoriasis is primarily responsible for market growth.
Which region will spearhead the growth in the global market?
North America accounts for a leading share of the global inflammatory skin diseases treatment market.
Related Reports
Inflammatory Skin Diseases Treatment Market